Sofinnova Investments, Inc.

Position in LQDA — Liquidia Corp

CIK 1631134 Menlo Park, CA

Back to LQDA Full portfolio

Position in LQDA

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

+$0 QoQ

Shares Held

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2020

5 quarters on record

Common Shares in LQDA Over Time

Shares Held

Position Value (USD)

Derivatives in LQDA

reported options exposure · as of Mar 31, 2026

CallValue

CallShares

PutValue

$18,870,000

PutShares

500,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

Sofinnova Investments, Inc. holds $184,364,892 across 3 Drug Manufacturers - Specialty & Generic names.

#	Ticker	Company	Shares	Value (USD)
1	UTHR	UNITED THERAPEUTICS Corp	160,070	$94,918,308
2	SUPN	Supernus Pharmaceuticals, Inc.	954,309	$49,328,232
3	BIOA	BioAge Labs, Inc.	2,293,788	$40,118,352

All Filings in LQDA

Export CSV

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$18,870,000	500,000	+100.0%	Put	Sole	2026-05-15
2025-09-30	$5,685,000	250,000	+69.2%	Put	Sole	2025-11-14
2020-12-31	$435,844	147,744	-78.3%	Shares	Sole	2021-02-16
2020-09-30	$3,342,647	679,400	-15.1%	Shares	Sole	2020-11-13
2020-06-30	$6,735,999	800,000	—	Shares	Sole	2020-08-13
No filing history on record for this holder in this stock.